StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts
Moderna (MRNA) excited analysts, though not as much investors, with its announcement this week that it planned to file for approval of its mRNA vaccine designed to protect older adults against respiratory syncytial virus...
3D Spatial Colorectal Cancer Maps Combine Molecular and Histological Features
Researchers at Harvard Medical School have combined histology with cutting-edge single-cell imaging technologies to create large-scale 2D and 3D spatial maps of colorectal cancer. The maps layer extensive molecular information on top of histological...
Environmental DNA Studies of Microbial Communities in Water Shed Light on Sources of Pollution
Environmental DNA (eDNA) analysis of microbial communities in a particular region’s water cycle can lead to a better understanding of why pollution is worse in some spots than others. It can also help local...
Researchers create the first ‘living medicine’ to treat drug-resistant lung infections
Researchers have designed the first 'living medicine' to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria which is naturally resistant to many types of antibiotics and is a common source...
Simulations and experiments reveal unprecedented detail about water’s motion in salt water
In salt water solutions, water molecules rapidly move around salt ions at a scale of more than a trillion times a second, according to both experiments and simulations led by scientists at New York...
NextPoint Therapeutics Reports $80 Million Series B for Novel Immuno-Oncology Programs
NextPoint Therapeutics has announced an $80 million Series B funding round to move two lead precision immuno-oncology programs into the clinic. Leaps by Bayer, Bayer AG’s impact investment arm, and Sanofi Ventures, Sanofi’s strategic...
2023 EVIDENT Organoid Conference to share the latest organoid innovations
Building on the momentum from last year’s conference, the 2023 Evident Organoid Conference will highlight organoid innovations that are poised to accelerate progress in drug research and discovery. Taking place on February 8, 2023,...
Multimodal sequencing achieves high-quality results from small volumes of frozen tumor specimens
New York, NY—January 18, 2023—Researchers at Columbia Engineering and Columbia University Irving Medical Center have invented a new RNA sequencing method that achieves high-quality results from small volumes of frozen tumor specimens. They demonstrated...
Governing Principles for Successful Biotechnology Companies – Pharmaceutical Executive
Pete O'Heeron, founder, chairman, and CEO of FibroBiologics, explains the key principles that biotechnology companies should follow.Pete O’Heeron, founder, chairman and CEO of FibroBiologics, has a long history of medical technology development experience, covering...
Intellectual property and assisted reproductive technology – Nature.com
As shown in the preceding sections, the patent landscape of IVG will likely differ substantially from that of its predecessor IVF. IVF was largely unencumbered by patents, at least in its formative stages, whereas...
